You are here: Industry Insights > china

News List

AstraZeneca, FibroGen give China bragging rights to first-in-class anemia drug approval fiercepharma
December 26, 2018
It is a rare event, if not a singular one in the biopharma world: A first-in-class drug developed by multinational pharma companies was filed first—and now approved first—in China, well before the U.S., EU or Japan.
Can China’s R&D sector shake its reputational issues in 2019? fiercebiotech
December 26, 2018
While 2018 was a big year for Chinese R&D on the whole, the sector hit the headlines for the wrong reasons.
Can China’s R&D sector shake its reputational issues in 2019? fiercebiotech
December 25, 2018
While 2018 was a big year for Chinese R&D on the whole, the sector hit the headlines for the wrong reasons.Most notoriously, researcher Jiankui He caused a furor in November after.....
Chi-Med and Lilly Amend 2013 Agreement contractpharma
December 21, 2018
Hutchison China MediTech has announced a change (“2018 Amendment”) to the 2013 License and Collaboration Agreement on fruquintinib with Lilly Shanghai, an affiliate of Eli Lilly and Company.
AstraZeneca, FibroGen give China bragging rights to first-in-class anemia drug approval fiercepharma
December 20, 2018
It is a rare event, if not a singular one in the biopharma world: A first-in-class drug developed by multinational pharma companies was filed first—and now approved first—in China, well before the U.S., EU or Japan.
Finland’s Mobidiag forms JV with Autobio to bring its infectious disease assays to China fiercebiotech
December 18, 2018
Mobidiag has paired up with China’s Autobio Diagnostics to help launch its infectious disease assays in the country through a new joint venture.
China has withheld deadly bird flu samples from U.S.: NYT fiercepharma
December 12, 2018
The routine exchange of important vaccine development material may have become a victim of the trade war between the U.S. and China.
Lonza to Establish Bio Mfg. Base in China contractpharma
December 12, 2018
Lonza entered an agreement with GE Healthcareunder which GE will deliver a biologics facility to Lonza in Guangzhou. The facility is part of a larger biomanufacturing initiative between GE Healthcare
Why China's flu vaccine supply is suffering this season fiercepharma
December 11, 2018
It isn’t a scene one would expect after the world battled a severe flu season. But in China, supply of flu vaccines this season has come down...
Big pharma loses out in China's latest procurement program fiercepharma
December 10, 2018
In a Battle of Waterloo-style defeat, off-patent drugs from big pharma firms lost major markets in China as the government adopted a novel procurement scheme to slash generic drug costs.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 38 39 Next page